Impact of Finasteride on Serum PSA Levels in Men With Benign Prostatic Hyperplasia: A Systematic Review

    October 2025 in “ International Journal of Social health ”
    Johan Rirpad Muis Tampubolon, Christiany Permata Sari Lumban Toruan
    Studysummary This systematic review reported that among men taking finasteride for benign prostatic hyperplasia, total PSA levels decreased by 30% to 50%, and free PSA by up to 45%, with reductions in prostate volume and PSA density observed as well.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ijsh.ph →
    Discuss this study in the Community →